Pasithea Therapeutics KTTA
NASDAQ KTTA
$0.54 +0.07 (+14.77%)
At close: Aug 21, 2026 · 4:00 PM EDT

Pasithea Therapeutics (KTTA) Interest Coverage Ratio (QoQ) (2023 - 2026)

Pasithea Therapeutics (KTTA) Interest Coverage Ratio (QoQ) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Pasithea Therapeutics 16.97 Mn 16.97 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 94.13%
Dec 31, 2025 -2,571.52%
Sep 30, 2025 18.39%
Jun 30, 2025 -107.10%
Sep 30, 2024 74.61%
Jun 30, 2024 2.37%
Sep 30, 2023 1.03%
Jun 30, 2023 -19.18%
Mar 31, 2023 98.42%